Tips on the Policy of Medical Insurance for Major Diseases in Jinhua City
Release time:
2020-08-14
Jinhua City critical illness medical insurance policy tips
1, Who should participate in critical illness insurance?
Jinhua City basic medical insurance for employees and basic medical insurance for urban and rural residents should participate in critical illness insurance, not to participate in the basic medical insurance, not to participate in the basic medical insurance alone.
The critical illness insurance benefits are consistent with the effective time of the basic medical insurance benefits, and if the basic medical insurance benefits are interrupted or terminated, the critical illness insurance benefits are interrupted or terminated at the same time.
2, Major illness insurance premium composition
Major illness insurance premium consists of basic premium and optional premium.
Basic premium. According to the government, the unit financing ratio 60% , the insured individual contribution ratio 40% to raise, and basic medical insurance premiums combined. The basic premium for 2018 is determined to be 50 yuan per person.
Option to pay premiums. The establishment of a major illness insurance optional premium program is to improve the ability to protect major illness insurance. The optional premium for each ,100 yuan is paid by individuals within the specified time, up to ,3 .
3, What are the benefits after taking part in serious illness insurance? If
fails to pay the optional premium or has been paid for less than three consecutive years, for the compliance medical expenses above the critical illness insurance minimum payment standard (2018 is 1.9 yuan), the critical illness insurance will be reimbursed 75% , with a maximum reimbursement of 40 yuan.
For those who have paid the premium for three consecutive years and 1 consecutive years, the reasonable medical expenses above the minimum payment standard (1.9 yuan in 2018 ) will be reimbursed for 75% for serious illness insurance, with a maximum reimbursement of 60 yuan; for those who choose to pay 2 for three consecutive years, the reasonable medical expenses above the minimum payment standard (1 yuan in 2018 ) will be reimbursed 80% for serious illness insurance, and the maximum reimbursement will be 80 yuan. For three consecutive years, choose to pay 3 copies, reasonable medical expenses above the minimum payment standard (yuan in 2018 ) will be reimbursed for.85% of by serious illness insurance, and the reimbursement amount will not be capped.
4, Poor People's Serious Illness Protection Inclination Mechanism
For the extremely poor and the minimum living security family members, all counties (cities, districts) can provide subsidies through medical assistance for the following compliant medical expenses. The specific personnel shall be determined by the civil affairs department.
For poor people and family members with minimum living security, each county (city, district) shall fully subsidize and pay elective premiums, and for marginal family members with minimum living security and other special difficulties stipulated by the people's government at or above the county level, at least elective premiums shall be paid with full subsidies. The specific number of subsidies shall be determined by each county (city, district).
Other people with special difficulties in Jinhua city refer to the severely disabled with certificates and the mentally ill with certificates, and the number of premium paid is determined to be 1 .
5, optional premium payment method
optional premium payment is consistent with the basic premium collection period, and the number of optional premium payments is selected by the individual during the collection period. Urban insured persons can go to urban 7 banks (ICBC, Bank of China, Agricultural Bank of China, China Construction Bank, Jinhua Bank, Chengtai Bank, Postal Savings Bank) to sign agreements to withhold and pay premiums from their contracted bank accounts. 2018 2# November and September, urban insured persons can also pay optional premiums to the financial public payment platform through Jinhua People's Society APP . Other counties (cities) insured personnel according to the county (city) social security agencies to arrange the way to pay.. If the optional premium is not paid within the collection period, it is allowed to pay in the year of serious illness insurance, and the corresponding treatment of the optional premium in this year is not enjoyed, and the payment period can be calculated continuously. Cross-year, as interrupted, again choose to pay, the payment period recalculated.
This year's optional premium collection period is determined to be 2018 1# December 8 to 5 .
Jinhua City Original Large Supplementary Medical Insurance and Major Illicit Disease Insurance Policy Connection
2017 For insured persons who have paid the original large supplementary medical insurance fee, if the number does not exceed 3 , the number of optional premium number for 2018 shall be determined according to the original number, if it is necessary to increase the number of copies, a new entrustment withholding agreement shall be signed. If it exceeds 3 copies, it shall be calculated as 3 copies.
The amount of 50% (hereinafter referred to as the amount of 50% ) of the original large supplementary medical insurance fees paid in 2017 is used to offset the premium paid by 2018 , and the shortfall is made up within the prescribed payment period. If the amount of 50% is more than ,300 yuan, will not be refunded in 2018 . If the treatment of the original large supplementary medical insurance system is higher than that of the serious illness insurance system, the settlement shall be made according to the original large supplementary medical insurance system.
Preferential Policies Remind
Year May Those who pay the optional premium before the end of June will be directly entitled to the treatment of paying for three consecutive years.
2018 5 March 31 , inpatient medical expenses settled before the optional premium payment (2018 1 September 1 to 2018 5 May 31 Sunrise Hospital) can be re-settled and enjoy the corresponding serious illness insurance optional payment treatment.
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page